XM does not provide services to residents of the United States of America.

U.S. STOCKS RTX, Molina



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>REFILE-BUZZ-U.S. STOCKS ON THE MOVE-RTX, Molina</title></head><body>

Removes Abbvie in the headline

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

U.S. stock index futures pared losses on Thursday after weaker-than-expected durable goods data lifted hopes for earlier interest rate cuts from the Federal Reserve. .N


At 9:01 ET, Dow e-minis 1YMc1 were up 0.12% at 40,159. S&P 500 e-minis ESc1 were up 0.02% at 5,473.25, while Nasdaq 100 e-minis NQc1 were up 0.09% at 19,220.25.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Bally's <BALY.N>, up 22.0%
** Molina Healthcare <MOH.N>, up 12.4%
** EMCOR Group <EME.N>, up 11.3%

The top three NYSE percentage losers premarket .PRPL.NQ:
** Edwards Lifesciences <EW.N>, down 24%
** Worthington Steel <WS.N>, down 22%
** QuantumScape <QS.N>, down 17.2%

The top two Nasdaq percentage gainers premarket .PRPG.O:
** Psyence Biomedical <PBM.O>, up 170.8%
** Predictive Oncology <POAI.O>, up 92.5%

The top two Nasdaq percentage losers premarket .PRPL.O:
** 2U <TWOU.O>, down 71.6%
** EzFill Holdings <EZFL.O>, down 39.8%


** Edwards Lifesciences EW.N: down 24.0% premarket
BUZZ - Plunges on weakness in sales of heart valves nL4N3JH0T6


** Honeywell International HON.O: down 4.9% premarket
BUZZ - Tumbles after FY24 profit forecast trim nL4N3JH18B


** Dow DOW.N: down 4.4% premarket
BUZZ - Falls after missing Q2 profit estimates nL4N3JH159


** Warner Bros Discovery WBD.O: down 4.4% premarket
BUZZ - Down after co fails to renew NBA broadcasting rights nL4N3JH0V1


** QuantumScape QS.N: down 17.2% premarket
BUZZ - Drops on wider Q2 losses nL4N3JH0UA


** Teradyne TER.O: down 9.4% premarket
BUZZ - Falls on revenue forecast let down nL4N3JH0WI


** Viking Therapeutics VKTX.O: up 15.1% premarket
BUZZ - Gains after obesity drug trial accelerated nL4N3JH0XO


** KLA KLAC.O: up 1.9% premarket
BUZZ - Firms as revenue forecast tops estimates on AI demand nL4N3JH0ZO


** International Business Machines IBM.N: up 2.8% premarket
BUZZ - Climbs after beating revenue estimates, forecasting software business growth nL4N3JH0YR


** Micron Technology MU.O: down 2.8% premarket

** Nvidia NVDA.O: down 0.7% premarket

** Advanced Micro Devices AMD.O: down 0.2% premarket

** Broadcom AVGO.O: down 0.2% premarket
BUZZ - U.S. chip stocks extend selloff on earnings, AI jitters nL4N3JH112


** Hasbro HAS.O: up 7.7% premarket
BUZZ - Jumps after smaller-than-expected drop in Q2 sales nL4N3JH169


** ServiceNow NOW.N: up 6.2% premarket
BUZZ - Jumps on raising subscription revenue forecast nL4N3JH16R


** Brunswick BC.N: down 2.1% premarket
BUZZ - Slides after trimming full-year forecast nL4N3JH1BS


** New York Community Bancorp NYCB.N: down 13.3% premarket
BUZZ - Slips after weak 2025 profit forecast, Q2 loss nL4N3JH1BG


** RTX RTX.N: up 3.3% premarket
BUZZ - Advances after hiking FY24 profit forecast nL4N3JH1DN


** Molina Healthcare MOH.N: up 12.4% premarket
BUZZ - Jumps after Q2 results beat nL4N3JH1IG


** West Pharmaceutical Services WST.N: down 14.1% premarket
BUZZ - Falls after annual forecast cut nL4N3JH1J5


(Compiled by Rajarshi Roy and Anuja Bharat Mistry)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.